Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial

Hiroaki Akamatsu, Nobuyuki Katakami, Isamu Okamoto, Terufumi Kato, Young Hak Kim, Fumio Imamura, Masaharu Shinkai, Rachel A. Hodge, Hirohiko Uchida, Toyoaki Hida

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Fingerprint Dive into the research topics of 'Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences